Urinary creatinine instability falsely increases the deoxypyridinoline/creatinine quotient.
The concentration of urinary deoxypyridinoline crosslinks (Dpd) (as in line 17)-normalized with respect to the urinary creatinine concentration is used as a biochemical marker of pathological bone resorption. The effect of various storage conditions on the stability of Dpd/creatinine in urine specimens was examined in a sample of 14 individuals without aseptic endoprosthetic loosening (control) and 14 patients with aseptic endoprosthetic loosening (AEL). In the control group, values of Dpd/creatinine measured after 1 day of storage at -20 degrees C were significantly greater (p < 0.005) than values measured in fresh urine specimens. In the AEL group, increases in urinary Dpd/creatinine values were less pronounced (NS to p < 0.05). Increases in Dpd/creatinine were primarily the mathematical consequence of significant decreases in urinary creatinine concentration in the control group (p < 0.0001) and the AEL group (p < 0.05, after at least 7 days of storage). The decrease in urinary creatinine concentration appears to reach a plateau--between 75% and 80% of the original value--after approximately 10 days of storage. To prevent falsely increased Dpd/creatinine quotients, we suggest that urinary creatinine should be measured exclusively in fresh urine specimens or consistently in specimens stored for at least 14 days at -20 or -80 degrees C.